These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38736008)

  • 1. Efficient hepatocyte differentiation of primary human hepatocyte-derived organoids using three dimensional nanofibers (HYDROX) and their possible application in hepatotoxicity research.
    Tong Y; Ueyama-Toba Y; Yokota J; Matsui H; Kanai M; Mizuguchi H
    Sci Rep; 2024 May; 14(1):10846. PubMed ID: 38736008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a hepatic differentiation method in 2D culture from primary human hepatocyte-derived organoids for pharmaceutical research.
    Ueyama-Toba Y; Tong Y; Yokota J; Murai K; Hikita H; Eguchi H; Takehara T; Mizuguchi H
    iScience; 2024 Sep; 27(9):110778. PubMed ID: 39280628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI).
    Miyata S; Saku N; Akiyama S; Javaregowda PK; Ite K; Takashima N; Toyoda M; Yura K; Kimura T; Nishina H; Nakazawa A; Kasahara M; Nonaka H; Kiyono T; Umezawa A
    Stem Cell Res Ther; 2022 Jan; 13(1):6. PubMed ID: 35012658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a 3D Cell Culture System Using Amphiphilic Polydepsipeptides and Its Application to Hepatic Differentiation.
    Enomoto J; Toba Y; Yamazaki H; Kanai M; Mizuguchi H; Matsui H
    ACS Appl Bio Mater; 2021 Sep; 4(9):7290-7299. PubMed ID: 35006958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.
    Davidson MD; Kukla DA; Khetani SR
    Integr Biol (Camb); 2017 Aug; 9(8):662-677. PubMed ID: 28702667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing.
    Bouwmeester MC; Tao Y; Proença S; van Steenbeek FG; Samsom RA; Nijmeijer SM; Sinnige T; van der Laan LJW; Legler J; Schneeberger K; Kramer NI; Spee B
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Proliferating Human Hepatocytes: In Vitro Hepatocyte Model for Drug Metabolism, Excretion, and Toxicity.
    Qiao S; Feng S; Wu Z; He T; Ma C; Peng Z; Tian E; Pan G
    Drug Metab Dispos; 2021 Apr; 49(4):305-313. PubMed ID: 33526515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of a Novel Hepatocyte Model Using Stem Cells for Pharmaceutical Research].
    Toba-Ueyama Y
    Yakugaku Zasshi; 2023; 143(11):905-909. PubMed ID: 37914337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical-based primary human hepatocyte monolayer culture for the study of drug metabolism and hepatotoxicity: Comparison with the spheroid model.
    Zhong Y; Yu JS; Wang X; Binas B; Yoo HH
    FASEB J; 2021 Mar; 35(3):e21379. PubMed ID: 33566373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of human induced pluripotent stem cell-derived hepatobiliary organoid with bile duct for pharmaceutical research use.
    Wang L; Koui Y; Kanegae K; Kido T; Tamura-Nakano M; Yabe S; Tai K; Nakajima Y; Kusuhara H; Sakai Y; Miyajima A; Okochi H; Tanaka M
    Biomaterials; 2024 Oct; 310():122621. PubMed ID: 38815455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
    Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
    Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.
    Bell CC; Dankers ACA; Lauschke VM; Sison-Young R; Jenkins R; Rowe C; Goldring CE; Park K; Regan SL; Walker T; Schofield C; Baze A; Foster AJ; Williams DP; van de Ven AWM; Jacobs F; Houdt JV; Lähteenmäki T; Snoeys J; Juhila S; Richert L; Ingelman-Sundberg M
    Toxicol Sci; 2018 Apr; 162(2):655-666. PubMed ID: 29329425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform.
    Harrison SP; Baumgarten SF; Chollet ME; Stavik B; Bhattacharya A; Almaas R; Sullivan GJ
    J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1047-1058. PubMed ID: 38529852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids.
    Mun SJ; Lee J; Chung KS; Son MY; Son MJ
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
    Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
    Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
    Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
    Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
    [No Abstract]   [Full Text] [Related]  

  • 19. A two-step strategy to expand primary human hepatocytes in vitro with efficient metabolic and regenerative capacities.
    Xie H; Li G; Fu Y; Jiang N; Yi S; Kong X; Shi J; Yin S; Peng J; Jiang Y; Lu S; Deng H; Xie B
    Stem Cell Res Ther; 2024 Sep; 15(1):281. PubMed ID: 39227965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated biomimetic array chip for establishment of collagen-based 3D primary human hepatocyte model for prediction of clinical drug-induced liver injury.
    Xiao RR; Lv T; Tu X; Li P; Wang T; Dong H; Tu P; Ai X
    Biotechnol Bioeng; 2021 Dec; 118(12):4687-4698. PubMed ID: 34478150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.